This inventor holds 2 USPTO granted patents. Top assignee: Kyowa Hakko Kogyo Kabushiki Kaisha. Active years: 1988.
Company Filing History:
Years Active: 1988
Title: Tohru Sugaya: Innovator in Antileukemia Agents
Introduction
Tohru Sugaya is a notable inventor based in Shizuoka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antileukemia agents. With a total of 2 patents to his name, Sugaya's work has the potential to impact cancer treatment significantly.
Latest Patents
Sugaya's latest patents focus on Mitomycin derivatives as antileukemia agents. These derivatives exhibit potent antitumor activity and are characterized by specific chemical formulas. The first patent describes Mitomycin derivatives having the formula: ##STR1## wherein A is ON--or R.sub.4 N.dbd.N--, with R.sub.4 selected from various groups, including optionally substituted heterocyclic groups. The second patent also details Mitomycin derivatives with potent antitumor activity, represented by the formula: ##STR1## wherein R represents lower alkyl, cycloalkyl, or unsubstituted or substituted aralkyl.
Career Highlights
Tohru Sugaya is associated with Kyowa Hakko Kogyo Kabushiki Kaisha, a prominent company in the pharmaceutical industry. His work at this organization has allowed him to focus on innovative solutions for cancer treatment. Sugaya's research and development efforts have positioned him as a key figure in the field.
Collaborations
Throughout his career, Sugaya has collaborated with notable colleagues, including Tokuyuki Kuroda and Koji Hisamura. These partnerships have fostered a collaborative environment that enhances the innovation process.
Conclusion
Tohru Sugaya's contributions to the development of antileukemia agents highlight his importance as an inventor in the pharmaceutical industry. His innovative work continues to pave the way for advancements in cancer treatment.